Kazia Therapeutics (KZIA) Total Liabilities (2017 - 2025)

Kazia Therapeutics' Total Liabilities history spans 6 years, with the latest figure at $9.2 million for Q2 2025.

  • For Q2 2025, Total Liabilities fell 55.84% year-over-year to $9.2 million; the TTM value through Jun 2025 reached $9.2 million, down 55.84%, while the annual FY2025 figure was $9.2 million, 55.84% down from the prior year.
  • Total Liabilities reached $9.2 million in Q2 2025 per KZIA's latest filing, down from $20.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $20.8 million in Q2 2024 to a low of $9.2 million in Q2 2025.
  • Average Total Liabilities over 4 years is $13.3 million, with a median of $11.7 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: surged 94.34% in 2024, then tumbled 55.84% in 2025.
  • A 4-year view of Total Liabilities shows it stood at $12.6 million in 2022, then dropped by 15.06% to $10.7 million in 2023, then soared by 94.34% to $20.8 million in 2024, then crashed by 55.84% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Total Liabilities are $9.2 million (Q2 2025), $20.8 million (Q2 2024), and $10.7 million (Q2 2023).